[HTML][HTML] Molecular mechanisms of chemoresistance induced by cisplatin in NSCLC cancer therapy
J Kryczka, J Kryczka… - International Journal of …, 2021 - mdpi.com
Cancer cells utilise several mechanisms to increase their survival and progression as well
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
J Kryczka, J Kryczka, KH Czarnecka-Chrebelska… - 2021 - agris.fao.org
Cancer cells utilise several mechanisms to increase their survival and progression as well
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
J Kryczka, J Kryczka… - International …, 2021 - search.proquest.com
Cancer cells utilise several mechanisms to increase their survival and progression as well
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
J Kryczka, JM Kryczka… - International …, 2021 - publicum.umed.lodz.pl
Cancer cells utilise several mechanisms to increase their survival and progression as well
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy.
J Kryczka, J Kryczka… - International …, 2021 - search.ebscohost.com
Cancer cells utilise several mechanisms to increase their survival and progression as well
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
J Kryczka, J Kryczka, K Czarnecka-Chrebelska… - 2021 - preprints.org
Cancer cells utilize a number of mechanisms to increase their survival and progression as
well as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
well as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy.
J Kryczka, KH Czarnecka-Chrebelska… - … Journal of Molecular …, 2021 - europepmc.org
Cancer cells utilise several mechanisms to increase their survival and progression as well
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
[PDF][PDF] Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
J Kryczka, J Kryczka… - Int. J. Mol …, 2021 - pdfs.semanticscholar.org
Cancer cells utilise several mechanisms to increase their survival and progression as well
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
[PDF][PDF] Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
J Kryczka, J Kryczka, KH Czarnecka-Chrebelska… - Int. J. Mol. Sci, 2021 - academia.edu
Cancer cells utilise several mechanisms to increase their survival and progression as well
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
J Kryczka, J Kryczka… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Cancer cells utilise several mechanisms to increase their survival and progression as well
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …
as their resistance to anticancer therapy: deregulation of growth regulatory pathways by …